Liz Parrish, the Founder and CEO of BioViva Science, is a humanitarian, entrepreneur, innovator, author, podcaster, and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach. Dedicated to the cause of improving and safeguarding more and more lives, Liz asserts, “We are focused on saving as many lives as possible by making tomorrow’s therapies available today. This is about life and death. Risk aversion and delaying the approval of therapies that have been successful in research simply kills”. Liz Parrish is founding member of the International Longevity Alliance, member of the Board of the Coalition for Radical Life Extension and affiliated member of the Complex Biological Systems Alliance.

Maria Trinidad Herrero is Professor of Human Anatomy at the Faculty of Medicine of the University of Murcia.

She is director of the Official Aging Research Institute of Murcia and head of the “Frailty” Group of the European Innovation Partnership on Active and Healthy Aging (EIP on AHA) of the Murcia Region Department of Health.

Director of the PhD Programme on Aging and Fragility (University of Murcia) (since 2017).

Director of the Healthcare Communication Chair (University of Murcia and ASISA Foundation) (since 2019).

Director of the Master’s Degree in Movement Disorders in Spanish: online master’s degree for Spanish speaking neurologists with students in different countries (since 2011).

Principal investigator of the Clinical and Experimental Neuroscience (NiCE) group of the Biomedicine Institute of Murcia (IMIB).

Her research is focused on brain aging and associated neurodegenerative diseases (Parkinson’s and Alzheimer’s diseases) with special interest in neuroinflammation, cognitive impairment and the effect of different strategies (such as natural smart foods and/or anti-inflammatory agents) on cognitive and emotional improvement. She is very interested in aspects of Gender, Health and Aging (Transnational Research Project GENDER ERA-NET H2020: “Going Forward”).

She has published over 150 scientific articles with an h index of 40/41 and has completed 6 five-year periods and 5 six-year periods of recognized research activity.

She has been the principal investigator on more than 20 regional, national and European scientific projects (for both basic and clinical research). She has directed 24 doctoral theses in her sphere of research, with 8 doctoral theses underway.

She has been a Member of the Royal Academy of Medicine of Murcia since 2006 (having been its president since 2018).

She is Correspondent and/or Honorary Member of Medical Academies in Latin America and a Member of national and international Academic and Scientific Neuroscience Societies.

She was president of the International Neurotoxicity Society (NTS) (2015-2017), and since 2012 has organized the biennial international symposium “Mechanisms of neurodegeneration and progression” with speakers on neurotoxicology from all continents.

She is co-director (together with Prof. J.A. Obeso and Prof. F. Micheli) of the International Master’s Degree on Movement Disorders in Spanish for neurologists (9 editions, from 2011 to date).

She was joint organizer of the Spanish Basal Ganglia Club (together with Prof. F. Grandas) for 18 years (1993-2012).

She has organized the Neuroclub in Murcia (meetings of clinicians specialized in the nervous system, every two weeks on Thursdays, at 8 a.m.) since 2007 (13 editions to date).

She has organized the International Brain Awareness Week in Murcia since 2003, with the aim of teaching the general public about brain activity and functioning, with 16 editions to date. She has obtained additional support from the DANA Alliance and FENS for several years.

She has organized the International Older Persons Week (first week of October) since 2015.

Head of Health at the Centre for Studies on Women and Gender (CEMUGE). University of Murcia (since 2018).

President of the Association of Women Scientists of the Region of Murcia (Lyceum de Ciencias) (since 2017).

Her main interests include equal opportunities, social justice and human rights. She has collaborated with the UN and UNESCO (Peace Culture) participating in outreach activities and Cooperation for Health Development in different Latin American countries, organizing events on equity and International Humanitarian Law.

Dr. Jay Sarkar is a Co-Founder for Turn Biotechnologies, a Stanford-born biotechnology company focused on multifaceted age-reversal via epigenetic reprogramming.  He completed his Ph.D. at Stanford University and has an Applied Physics and Electrical Engineering background that helps him focus on studying aging and biology from an information science and dynamical systems perspective. His scientific work has shown that while aging is generally associated with tissue and organ dysfunction, these can be considered the emergent consequences of fundamental transitions in the cellular state of cellular physiology. These transitions have multiple manifestations at different levels of cellular architecture and function, but the central regulator of these transitions is the epigenome, the most upstream dynamic regulator of gene expression. Reproduction is the only general phenomenon in nature where the age of (parental) cells is truly reset – to produce an embryo and ultimately an age zero offspring. Here we present a technology that captures part of this age reset mechanism but uses transient reprogramming to drive more youthful phenotypes without the full reset back to an embryo. This reprogramming technology is distinct from previous anti-aging/pro-longevity interventions, as instead of just modulating a few identified aging pathways, reprogramming engages a global and balanced state transition in the case of reproduction, or state of perturbation in our transient approach, which he shows leads to a multifaceted age-reversal effect at the DNA, metabolic, whole cell, and local environment levels.

Doctor specialising in Family and Community Healthcare.

PhD in Pharmacology from the University of Valencia.

Her healthcare work is focused on the field of Palliative care and care in the home, an area in which she carries out her research and teaching activities. She currently practices as Doctor of the Home Hospitalisation Unit of the Valencian Oncology Institute Foundation (IVO). Also relevant is the performance of activities addressed to patients regarding the importance of health education during the course of illness.

Among her merits, we can highlight that she is qualified as an Expert in Bioethics by the University Jaime I and Expert in Palliative Care.

She is currently an active member, forming part of the management board, of the Valencian Society of Palliative Medicine.

Maria Entraigues Abramson is currently Global Outreach Coordinator for the SENS Research Foundation co-founded by Dr. Aubrey de Grey. She’s been part of SRF since its founding days (2009) and before that, part of Methuselah Foundation (co-founded by Dave Gobel and Dr. Aubrey de Grey).

She is also a science and technology communicator and one of the leading voices in the field of Longevity, presenting every year at international conferences in the topic of Longevity and the future of health. Her passion and strong involvement in science and technology, combined with her skills in Public Relations and networking, positioned her as one of the main “connectors” in the field, in charge of building new critical relationships, spreading the word about the mission and raising funds for research.

She is also a singer, actress, composer, journalist, and private pilot.

Maria is a radical-change believer and spends her multifaceted life working on facilitating disruptive change to help the world. You can find her giving a scientific talk, singing live for thousands of people, composing and acting for a Hollywood film, doing music journalism, writing about aging, or flying an airplane. But her main goal is to make sure one day aging doesn’t mean to get sick.

She is also the co-founder of Longevity Bridge, dedicated to creating resources for optimal health – currently developing new assays to measure important biomarkers of aging.

She currently sits in the Boards of different organizations working towards a healthier and better future like the Coalition for Radical Life Extension, International Longevity Alliance, California Transhumanist Party and Lifeboat Foundation. She is also a member of The Three Hundred.

She’s constantly being interviewed throughout the media as an Ambassador of radical life extension and Cryonics, as well as being featured internationally on different documentaries and TV shows.

You can read her newly published essay on aging in the book “The Transhumanism Handbook” among a number of other Longevity global leaders.

He holds a degree in Economics and Business Administration from the University of Zaragoza and a PhD in Economics from the Autonomous University of Barcelona. He is Professor of the Foundations of Economic Analysis at the UNED, where he was Director of the International PhD School and where he currently coordinates the Doctoral Programme in Economics and Business. He was Director General of the Institute of Fiscal Studies and Director of the FEDEA-BBVA Chair of New Consumers at the Foundation for Applied Economics Studies. He is currently an Affiliate Researcher at Economics for Energy. The areas in which he has developed his research include the analysis of the behaviour of individuals in consumer decisions and job offers, as well as in the simulation and evaluation of the effects of public policies. He has been and is a Member of the Scientific Committee or of the Advisory Committee or Editor of several academic journals and he has published the results of his research in national and international journals in his specialty.

Bruno Vellas is chair of the Gerontopole & Department of Geriatric Internal Medicine at the Toulouse University Hospital and is member of INSERM UMR 1027, chair of the WHO Collaborating Center for Frailty, Clinical Research and Geriatric Training. He is of Chairman of the Scientific Committee of the plan Grand Age (National French Plan on Ageing). He studied medicine in Toulouse and received the degree of Doctor of Medicine in 1987 and a PhD in Pysiopathology in 1990. He had a doctoral training in nutrition and aging at the University of New Mexico, USA, Clinical Nutrition Lab, School of Medicine from 1987 to 1988. His main interests are: development of aging and geriatric clinical research and care. His research and care has been supported by several European, national and international research grants. He is the founder of the Gerontopole to develop innovation and research for older adults. He is the author and co-author of more than 858 publications in peer review journals since 1987, Index H: 81. He serves as editor, editorial committee member and reviewer of several major journals. He is adjunct professor at the Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA and is member of the scientific advisory board of several major scientific institutions in France, EU, Japan and the US. Since 2016, he is titular member of the French National Academy of Medicine, Officier de la Légion d’Honneur, and was recipient of the Palmes Académiques in 2016. He is the past president of the IAGG (International Association of Gerontology and Geriatrics) a NGO with a seat at the United Nations, and the founder of the EADC (European Alzheimer’s Disease Consortium), the CTAD (Clinical Trial in Alzheimer’s Disease conference) and the ICFSR (International Conference for Frailty and Sarcopenia Research). He is the chair of the WHO Collaborating Center for Frailty, Clinical Research and Geriatric Training since september 2017 and principal investigator on the INSPIRE Project on Geroscience.

Graduate in Biology and PhD in Physiology from the University of Murcia. He worked for four years in the Molecular Nutrition Group of the Institute of Aquaculture at the University of Stirling (Scotland, United Kingdom) thanks to an extension grant for postdoctoral studies abroad from the Ramón Areces Foundation and an Intra-European Marie Curie grant to develop new fish models for the study of ageing, particularly the circadian system of these animals. He has been working since 2017 as a researcher in the Chronobiology Group of the University of Murcia on a project to understand the mechanisms associated with the ageing of the circadian system of vertebrate models (fish of the Nothobranchius genus), which connects environmental light, melatonin and the lipids that make up cell membranes, particularly mitochondria.

Carlos Félix Sánchez Ferrer studied Medicine at the Universidad Autónoma de Madrid (UAM), where he graduated in 1981 and received his PhD in 1984. Having been awarded scholarships from the Spanish Health Research Fund (FIS) and the Mayo Foundation, he held a postdoctoral position during 1987 at the Mayo Clinic and Mayo Medical School (Dept. of Physiology), followed by another at the Medical College of Wisconsin (Dept of Physiology) thanks to an International Research Fellowship of the Fogarty International Center (National Institutes of Health, USA). He was a Lecturer in Pharmacology between 1987 and 2005 and has been Professor of this subject since 2005, always in the Department of Pharmacology and Therapeutics of the UAM. He has been the Director of this Department since 2013. He was Vice Dean of Research of the Faculty of Medicine of the UAM between 2000 and 2007 and has been Correspondent Academic of the National Royal Academy of Medicine of Spain since 2002. Together with Prof. Peiró, he leads a UAM and IdiPAZ research group named with the acronym FARMAVASM, dedicated to the study of the mechanisms that produce deterioration of the vascular function in pathological conditions, such as diabetes mellitus and obesity, as well as the analysis of the underlying cellular and molecular mechanisms of vascular aging. As pharmacologists, a fundamental aim of the group is to characterise new therapeutic targets that make it possible to prevent or delay vascular aging, using for this purpose different experimental approaches, from human vascular cell cultures to animal models and patient studies. He collaborates with various prestigious national and foreign researchers and has authored more than one hundred scientific publications in international journals, the majority in the first quartile. He has co-directed 18 doctoral theses and has been the lead researcher on 25 competitive projects at regional, national and international level.

He is a co-founder and CEO at Senolytic Therapeutics Inc., a pharmaceutical company that develops a novel class of medicines by targeting senescence cells. He is also supporting investments and strategic partnerships at Life Biosciences Inc. in Europe. Currently, Marc is a strategic advisor at Ninevah Therapeutics, Cebiotex, Retinset Therapeutics and Origen Ventures. He is a co-founder and Partner at Chasing Science, an early-stage biomedical venture builder. Marc is also a founder and Advisor at Tech & Business Innovation (TBI), an academic firm focused on knowledge exchange and corporate-academic partnerships. Marc brings experience as advisor and board member for multiple organizations and as co-founder of several companies. Marc has implemented Entrepreneurs-in-Residence programs at several academic institutions such as IRB Barcelona. From 2010 to 2012, Marc was working for Isis Innovations/University of Oxford as an associate consultant in Spain and LATAM. From 2007 to 2011, Marc was working at Endor, a nanomedicine company based in Spain. During this period, he was R&D director (drug-delivery nano-systems for cancer therapy) and Business Development Director (launched several nanotechnology products to the cosmetic and textile markets).
Previously, Marc also worked in the pharmaceutical environment in Novartis. He also collaborated with other research institutions such as Cancer Research UK and Boston College during his academic career. Marc gained a DPhil in Biochemistry from the University of Oxford in 2006, and a Harvard Business School PLD Program in 2011. Marc also gained a M.Sc. in Chemical Engineering in 2001 and a B.Sc. in Chemistry from IQS (Barcelona) in 2000.